SynthesisFrontiers in pharmacology2023

Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis.

Zongyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.